Increasing rates of obesity, lack of physical activity, sedentary behavior, and frequent alcohol consumption are major lifestyle-related risk factors for breast cancer. In fact, it has been estimated that about one-third of breast cancer cases are attributable to factors women can change. Most research has focused on examining the impact of one single exposure on breast cancer risk while adjusting for other risk modifiers. Capitalizing on big data, major efforts have been made to evaluate the combined impact of well-established lifestyle factors on overall breast cancer risk. At the individual level, data indicate that even simple behavior modifications could have a considerable impact on breast cancer prevention. Moreover, there is emerging new evidence that adopting a healthy lifestyle may be particularly relevant for women with hereditary susceptibility to breast cancer. On the absolute risk scale, studies suggest that the presence of certain risk factors, such as excessive body weight, had a substantially higher impact on breast cancer risk if women had a hereditary predisposition to cancer. The existing body of knowledge gives the medical professionals guidance as to which factors to focus on when counseling patients. However, well-designed randomized controlled trials utilizing objective methods are crucial to providing concrete recommendations.

Four out of ten cancer cases among US women are believed to be preventable by healthier lifestyle choices [1]. In particular, excessive body weight, physical inactivity, frequent alcohol consumption, and the increased availability of calorie-dense foods are adding to the growing breast cancer burden. Furthermore, these unhealthy lifestyle choices threaten to offset the steady decline in cancer mortality [2]. Yet, the American Society of Clinical Oncology identified serious gaps in public knowledge about lifestyle factors contributing to cancer risk: Despite obesity being a leading preventable cause of cancer, only 31% of the people surveyed recognized the link [3]. Major public health efforts are necessary to improve public awareness and to incorporate lifestyle recommendations into clinical practice which can be applied both at the individual and the collective level. Here, we review the emerging evidence on modifiable lifestyle factors across the lifespan that offer an opportunity for breast cancer prevention by means of healthier living - even in women with genetic susceptibility to breast cancer.

Studies considered for this review were obtained from PubMed searches based on the search terms breast cancer, hereditary breast cancer, BRCA, risk factor, lifestyle, weight, obesity, physical activity, exercise, sedentariness, diet, and smoking. We critically reviewed references of all relevant publications (including review articles) to identify additional articles. Only studies published after 2002 that evaluated breast cancer risk were included. Studies examining the impact of lifestyle factors on clinical outcomes among breast cancer survivors were excluded.

A large body of research points to the fact that obesity increases a person's risk for at least 13 different types of cancer [4,5], including postmenopausal breast cancer. The association between body weight and breast cancer risk varies by menopausal status: Evidence suggests that a high body mass index (BMI) may be associated with a decrease in premenopausal breast cancer risk, but is strongly associated with an increased risk of developing postmenopausal breast cancer [6]. A meta-analysis of cohort studies showed an 18% decreased risk of premenopausal breast cancer per 5 kg/m² increase in BMI during young adulthood [7]. In the Nurses' Health Study II, women indicating a BMI of ≥27.5 kg/m² at age 18 years had a 39% decrease in premenopausal breast cancer risk compared to their lean counterparts (BMI of 20.0-22.4 kg/m²) [8]. The reduction in premenopausal breast cancer risk with increasing BMI during the teen years has been attributed to irregular menstrual cycles and ovulatory infertility. Yet, after adjusting for these factors in the Nurses' Health Study II, they showed only little impact on the association [8]. Research suggests that body fatness at young ages may be associated with slower adolescent growth and lower levels of both progesterone and insulin-like growth factor 1 (IGF-1) [7,9]. Still, the underlying biological mechanisms are not well-delineated and warrant further evaluation. Examining the role of obesity in premenopausal breast cancer in terms of specific tumor subtypes, Pierobon and Frankenfeld [10 ]observed a positive association between obesity and triple-negative breast cancer among premenopausal women, reporting an increase in risk of 43% (95% confidence interval (CI) 1.23-1.65).

Notably, adipose tissue is a major source of estrogen synthesis in postmenopausal women, an established risk factor in breast carcinogenesis, and evidence supports a clear association between body fatness and a substantially increased risk of postmenopausal breast cancer [11]. In a meta-analysis of prospective studies examining the association between BMI and postmenopausal breast cancer risk, Renehan et al. [12 ]found a 12% increase in risk per 5 kg/m² increase in BMI. Carpenter et al. [13 ]provided evidence that the positive association between BMI and postmenopausal breast cancer risk may be modified by family history of breast cancer: Postmenopausal women who had at least 1 first-degree relative with breast cancer and who had a current BMI of ≥27.1 kg/m² were at a 2.9 times greater breast cancer risk than women with a positive family history whose current BMI was <21.7 kg/m² (95% CI 1.86-4.54).

Several studies examined the association between weight change throughout the women's lifespan, i.e., mostly weight gained from early adulthood to present, and subsequent breast cancer risk [11]. A key limitation of this measure is that it may miss any weight loss at varying time points in a woman's lifespan. Eliassen et al. [14 ]showed that a weight gain of at least 25 kg since age 18 years elevated postmenopausal breast cancer risk by 45% (95% CI 1.3-1.7, p-trend < 0.001) compared to women whose weight remained stable (weight fluctuations of ≤2 kg). A weight gain of at least 10 kg following menopause conferred an 18% increased risk of breast cancer compared to a stable weight at the same period of time (95% CI 1.0-1.4, p-trend = 0.002) [14]. Based on data from the Women's Health Initiative observational study, Chlebowski et al. [15 ]demonstrated that a modest weight loss after menopause, i.e., a relative weight loss of at least 5% of one's body weight, could lower breast cancer risk by 12% relative to stable weight (95% CI 0.78-0.98).

In addition to a higher risk of developing breast cancer, overweight women tend to present with larger tumors at the time of diagnosis when compared with their normal-weight counterparts [16].

Case-control studies suggest that a woman's body fat distribution may influence the hormone receptor status of the breast cancer she is susceptible to [17]. Both general and central obesity have been associated with greater breast cancer risk [11]. Obese women with larger amounts of subcutaneous fat, as measured by BMI, may have a significantly higher risk of developing hormone receptor-positive breast cancer. In contrast, larger amounts of visceral fat, indicated by a high waist-to-hip ratio, may be associated with a greater risk of developing hormone receptor-negative breast cancer, independent of BMI [17].

As scientists continue to explore the relationship between obesity and cancer, there is rapidly increasing interest in the insulin signaling pathway [18]. Based on data from the Women's Health Initiative Study, Gunter et al. [19 ]conducted a case-control analysis to prospectively examine the incidence of postmenopausal breast cancer among nondiabetic women. Their findings suggest that insulin levels were positively associated with breast cancer risk (hazard ratio (HR) 1.46; 95% CI 1.00-2.13; p-trend = 0.02), confirming that hyperinsulinemia is an independent risk factor for postmenopausal breast cancer. While experimental evidence supports a synergistic interaction between estrogen receptor activation and increased IGF-1 signaling with regard to breast carcinogenesis, the data from the prospective European Prospective Investigation into Cancer and Nutrition (EPIC) cohort indicate that higher circulating IGF-1 levels may increase the risk of hormone receptor-positive breast cancer diagnosed after age 50 years (odds ratio (OR) 1.38, 95% CI 1.01-1.89; p-trend = 0.01) [20].

Numerous scientific studies have demonstrated a protective role of physical activity in breast cancer etiology, and anthropometric factors do not attenuate this association [11]. Collectively, the evidence supports an inverse association between physical activity and breast cancer, with a risk reduction of 20-30% when comparing the most physically active to the least active women [21,22] and depending on the study design, population studied, and level of physical activity. The relationship exists for both pre- and postmenopausal women, with greater risk reductions observed among postmenopausal women [7,21]. The magnitude of risk reduction appears to be stronger for strenuous than for moderate levels of exercise [21,23].

Both retrospective and prospective studies confirmed a dose-response relationship between increasing levels of physical activity and breast cancer risk, and the association was true for all pathological subtypes of cancer [11,24]. In the Nurses' Health Study II, adolescent physical activity from ages 14-17 years was inversely associated with premenopausal breast cancer risk, with a risk reduction of 19% (95% CI 0.69-0.95) [25].

Even though research provides consistent findings linking physical activity to breast cancer, a big limitation of these studies is the reliance on women's self-reports instead of objectively measured data. To date, only one research group used accelerometer data to evaluate the association between physical activity level and breast cancer incidence [6]. Among 2,160 Polish women, Dallal et al. [26 ]reported a 61% decrease in risk for women in the highest quartile of moderate-to-vigorous accelerometer-based measures of physical activity compared to women in the lowest quartile (95% CI 0.27-0.56; p-trend < 0.0001).

Long amounts of time spent sitting have been shown to influence breast cancer risk, and the positive association seems to be independent of physical activity. Based on accelerometer data and after adjustment for physical activity, Dallal et al. [26 ]found an 81% increased risk of breast cancer in women with the longest sedentary time compared to women with the shortest duration of sitting (95% CI 1.26-2.60; p-trend = 0.001). With regard to occupational sedentariness, Johnsson et al. [27 ]observed a 20% increased risk of breast cancer diagnosed before age 55 years (95% CI 1.05-1.37) compared to women with less sedentary occupations. The results were replicated in a study of African-Americans evaluating the association between total time spent sitting and subsequent breast cancer risk [28].

In separate studies, alcohol consumption emerged as the strongest and most consistent dietary factor linked with breast cancer. In 2017, the World Cancer Research Fund and the American Institute for Cancer Research (WCRF/AICR) published a dose-response meta-analysis for premenopausal breast cancer which revealed a 5% increased risk per 10 g of ethanol consumed per day (95% CI 1.02-1.08) [7]. For postmenopausal breast cancer, the researchers observed a 9% increased risk per 10 g of ethanol consumed per day (95% CI 1.07-1.12) [7]. Findings indicate that frequent alcohol consumption may put a woman with at least 1 breast cancer-affected first-degree relative at greater risk for breast cancer than women with no family history [29].

Case-control studies suggest that balanced diets, consisting of substantial amounts of wholegrain, fiber, fruits, and vegetables, are associated with reduced breast cancer risk, especially when adopted early in life, i.e., during childhood [6]. Based on the Nurses' Health Study II, Harris et al. [30 ]reported that an adolescent and early adulthood dietary pattern characterized by sugar-sweetened soft drinks, refined grains, red and processed meat, and margarine, and low intake of leafy vegetables and cruciferous vegetables was associated with an increased incidence of premenopausal breast cancer (HR 1.35; 95% CI 1.06-1.73; p-trend = 0.002 for adolescent diet, and HR 1.41, 95% CI 1.11-1.78; p-trend = 0.006 for early adulthood diet) [30]. In 2017, the WCRF/AICR indicated that only limited evidence exists for a decrease in breast cancer risk associated with the consumption of foods containing carotenoids or the consumption of non-starchy vegetables, respectively [7]. In fact, randomized controlled trials for studying diet-cancer relationships have failed to demonstrate a significant impact of diet on breast cancer risk. Only limited and non-significant trends exist for an association between a low-fat dietary pattern and reduced breast cancer risk [7,11]. The EPIC study investigated the association between the adherence to the Mediterranean diet and risk of breast cancer among 335,062 European women, with an average follow-up of 11 years. The data indicate that adherence to the Mediterranean diet excluding alcohol was associated with a decrease in risk for postmenopausal breast cancer (HR 0.93; 95% CI 0.87-0.99; p-trend = 0.037), particularly in the case of hormone receptor-negative tumors (HR 0.80; 95% CI 0.65-0.99; p-trend = 0.043). The PREDIMED trial was the first randomized controlled trial to support these findings, providing additional evidence for a protective effect of a Mediterranean diet, supplemented by extra virgin olive oil, in breast cancer, with a decrease in risk of 68% (95% CI 0.13-0.79) [31]. Well-designed prospective studies focusing on diet patterns rather than dietary components are warranted to address the critical gap in the current literature regarding the role of diet in breast cancer risk.

The relationship between smoking and breast cancer has been studied extensively; however, findings have been inconclusive [11]. Emerging evidence derived from better-designed epidemiologic studies suggests a positive association between breast cancer and tobacco consumption in populations with high smoking prevalence, higher pack-years, and long durations of smoking [11,32,33,34]. In the largest cohort examined, Dossus et al. [33 ]provide evidence that both active and passive smoking contribute to a substantially increased risk of breast cancer, particularly for increasing pack-years of active smoking between menarche and first full-term pregnancy (HR 1.73, 95% CI 1.29-2.32 for every increase of 20 pack-years).

Since cancer predisposition is multifactorial in origin, caused by a complex interplay between genetic factors and a multitude of non-genetic exposures such as environmental influences, reproductive and lifestyle factors - many of them occurring concomitantly, modifiable risk assessment cannot simply be reduced to a single hypothetical factor. Failure to include relevant exposures most possibly results in decreased power and biased risk estimates, whereas considering a large amount of potential influences may lead to challenges in both statistical implementation and interpretation, particularly in correlated factors. Further, both preventive and harmful lifestyle behaviors tend to appear in clusters. Recently, major efforts have been made to evaluate the combined impact of selected lifestyle factors on breast cancer risk. Based on data from the EPIC study, McKenzie et al. [35 ]evaluated a healthy lifestyle index score (HLIS) to investigate the joint effect of 5 modifiable lifestyle factors on postmenopausal breast cancer risk. The HLIS is composed of diet, physical activity, smoking, alcohol consumption, and anthropometric factors, with higher values indicating healthier behaviors. With each point added to a person's HLIS, postmenopausal breast cancer risk decreased by 3%, suggesting that an overall healthy lifestyle may substantially lower the risk of developing postmenopausal breast cancer. Ellingjord-Dale et al. [36 ]replicated these findings in a Norwegian cohort. Risky lifestyle behaviors were defined as follows: ever-smoking, weekly consumption of >2 glasses of alcoholic beverage, <3 h leisure time physical activity weekly, ever-use of menopausal hormone therapy, and BMI > 25 kg/m². There was a linear dose-response relationship between the number of risky lifestyle behaviors and hormone receptor-positive breast cancer: Women who had 5 risky lifestyle behaviors were at a 2.38 times greater risk of luminal A-like breast cancer compared to women with no risky lifestyle behaviors (95% CI 1.58-3.59; p-trend < 0.0001). Taken together, these findings show preliminary evidence that an overall healthy lifestyle may contribute to a sizeable decrease in breast cancer risk.

Women who inherit a deleterious BRCA1 or BRCA2 mutation face a high lifetime risk of developing breast cancer, between 69 and 72% [37] compared to 12% in the general population [38]. Among BRCA mutation carriers, primary prevention of breast cancer is limited to prophylactic bilateral mastectomy; however, mutation carriers frequently inquire about less invasive prevention options [39]. Both the incomplete penetrance and the regional differences in penetrance of an inherited BRCA1 or BRCA2 mutation suggest that environmental exposures may influence risk [40]. While various reproductive and hormonal factors have shown to impact BRCA-associated cancer risk [41], suggestive evidence exists that lifestyle factors, including body weight, adolescent physical activity, calorie restriction, and non-smoking, may contribute to a decrease in the number of BRCA-associated breast cancer cases [42,43].

In an early study, King et al. [44 ]reported that the risk for early-onset breast cancer was lower if gene mutation carriers were born before 1940, had given birth, had a healthy weight at menarche and age 21, and were physically active during adolescence. Kotsopoulos et al. [45 ]showed that a weight loss of at least 10 pounds between ages 18 and 30 was associated with a 53% decreased risk of BRCA-associated breast cancer between ages 30 and 49 (95% CI 0.28-0.79). Pijpe et al. [46 ]demonstrated a significant 42% reduction in risk (95% CI 0.35-0.94; p-trend = 0.05) with increasing levels of physical activity prior to, but not after, age 30. In addition to mechanistic data linking physical activity to reductions in endogenous sex hormone levels, lower IGF-1 levels, and an improved immune function [22,47], gene-environment interactions are of increasing research interest with regard to BRCA-related tumors. Using an in vivo model, Wang et al. [48 ]demonstrated that prepubertal physical activity was associated with a significant increase in BRCA1, p53, estrogen receptor (ER)-α, and ER-β mRNA expression in mammary glands of adult rats versus control (unexercised) rats (p < 0.03). We recently reported that, even in a small study cohort of 68 BRCA mutation carriers, study participants indicating a higher level of physical activity during adolescence had a significantly lower cancer prevalence (p = 0.019) [49]. Additionally, we observed a significantly higher cancer prevalence in smokers compared to non-smokers (p < 0.001) [49]. Pettapiece-Phillips et al. [50 ]showed that uninterrupted sedentary behavior was associated with decreased BRCA1 mRNA expression (p = 0.02). Whether this finding translates into a potentially harmful effect with regard to BRCA-associated cancer risk is under active study. Nkondjock et al. [51 ]reported a positive association between total energy intake and BRCA-associated breast cancer risk when comparing the highest tertile of calorie intake with the lowest tertile (OR 2.76, 95% CI 1.10-7.02; p-trend = 0.026). In another analysis, Nkondjock and Ghadirian [52 ]demonstrated that a balanced diet of high quality was associated with a 65-82% decreased risk of BRCA-related breast cancer (OR 0.35, 95% CI 0.12-1.02; p-trend = 0.034 for Diet Quality Index-Revised (DQI-R) and OR 0.18, 95% CI 0.05-0.68; p-trend = 0.006 for Canadian Healthy Eating Index (CHEI)). However, analyses were all limited by a retrospective study design with small sample sizes, providing significant potential for biases.

Trygvadottir et al. [53 ]investigated changes in penetrance over time with regard to the cumulative breast cancer incidence before age 70 years in Icelandic women. The investigators found a 4-fold increase in the cumulative incidence of breast cancer between 1920 and 2000 among BRCA2 mutation carriers (from 18.6 to 71.9%) and women in the general population (from 1.8 to 7.5%). Indeed, on the absolute risk scale, the adoption of a healthy lifestyle will affect breast cancer risk to a considerably greater extent among women with a hereditary susceptibility to breast cancer compared to women without a family history of cancer. Quante et al. [54 ]evaluated the performance of the IBIS Breast Cancer Risk Evaluation Tool, with and without accounting for BMI, for predicting breast cancer occurrence in postmenopausal women. The authors found a significant absolute BMI-induced difference in IBIS-assigned 10-year risk, comparing women with a BMI of 27 kg/m² to women with a BMI of 21 kg/m² with regards to hereditary predisposition to cancer: The absolute BMI-induced difference in the model-assigned 10-year risk ranged from 0.3% for women with neither affected first-degree relatives nor a BRCA1 mutation to 4.5% for mutation carriers with 3 breast cancer-affected relatives. Additionally, at the individual level, Quante et al. [54 ]demonstrated that overweight women who had originally been classified as ‘high risk' patients for developing breast cancer could be reclassified as ‘low risk' only by reducing their BMI.

Among BRCA mutation carriers, two independent studies demonstrated that the receipt of a positive BRCA1/2 genetic test result contributed to significant lifestyle changes [55,56]. We recently reported that women with hereditary BRCA mutations tend to adopt healthier lifestyles compared to women from the general population [49]. However, radical changes in health behavior could potentially result in the uptake of harmful behaviors. For instance, given the widespread use of folic acid supplementation, research efforts have been made to elucidate the relationship between folate status and breast cancer risk. Even though the role of folate in the development of BRCA-related breast cancer is not clear, Kim et al. [57 ]indicated that elevated plasma folate concentrations might be associated with an increased risk for breast cancer among BRCA mutation carriers.

A prospective evaluation of multiple lifestyle behaviors, collected at various time points, with the utilization of objective methods to capture body size, physical activity, and dietary habits, is crucial to provide evidence-based, safe, and effective strategies for this high-risk group. Moreover, providing measurable data is necessary to facilitate the counselees' understanding of both non-modifiable and modifiable risk information [58].

Aiming to elucidate the impact of non-genetic modifiers on BRCA-associated breast cancer risk, the LIBRE study is the first prospective randomized lifestyle intervention trial worldwide involving cancer-affected and -unaffected BRCA mutation carriers [59,60]. The purpose of the randomized, 2-armed (1:1), multicenter, interdisciplinary, prospective, and open study is to demonstrate that a structured intervention program, consisting of endurance training paired with the Mediterranean diet, will improve BMI, physical fitness, and adherence to the Mediterranean diet pattern. The long-term goals of the trial are to demonstrate a decrease in breast cancer risk, an inhibited progression of disease, and a reduced cancer mortality rate in BRCA mutation carriers following a healthy lifestyle. Ultimately, by utilizing a variety of objective methods and by analyzing the joint effects of modifiable lifestyle factors, the LIBRE trial aims to provide data on lifestyle options of preventive value that could be translated into the practice of genetic counseling.

Building upon the growing evidence linking lifestyle factors to (BRCA-associated) breast cancer, we suggest that action should be taken to incorporate timely lifestyle recommendations into the daily practice of clinicians and genetic counselors. To begin with, maintaining a healthy weight, limiting alcohol consumption, smoking cessation, and being physically active on a regular basis is a message medical practitioners and patients can act upon until more precise recommendations can be made.

The authors declare that they have no conflict of interest.

1.
Islami F, Goding Sauer A, Miller KD, et al: Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin 2018;68:31-54.
2.
Ma J, Ward EM, Siegel RL, Jemal A: Temporal trends in mortality in the United States, 1969-2013. JAMA 2015;314:1731-1739.
3.
ASCO: National Cancer Opinion Survey, 2017. www.asco.org/research-progress/reports-studies/national-cancer-opinion-survey.
4.
Massetti GM, Dietz WH, Richardson LC: Excessive weight gain, obesity, and cancer: opportunities for clinical intervention. JAMA 2017;318:1975-1976.
5.
Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol 2018;6:95-104.
6.
Kerr J, Anderson C, Lippman SM: Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol 2017;18:e457-471.
7.
World Cancer Research Fund International/AICR: Continuous Update Project Report: Diet, Nutrition, Physical Activity and Breast Cancer. 2017. wcrf.org/breast-cancer-2017. All CUP reports are available at wcrf.org/cupreports.
8.
Michels KB, Terry KL, Willett WC: Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 2006;166:2395-2402.
9.
Dowsett M, Folkerd E: Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis. Breast Cancer Res Treat 2015;149:1-4.
10.
Pierobon M, Frankenfeld CL: Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat 2013;137:307-314.
11.
Li C (ed): Breast Cancer Epidemiology. New York, Springer, 2010.
12.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.
13.
Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L: Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer 2003;106:96-102.
14.
Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE: Adult weight change and risk of postmenopausal breast cancer. JAMA 2006;296:193-201.
15.
Chlebowski RT LJ, Anderson GL, Simon M, et al: Weight change in postmenopausal women and breast cancer risk in the Women's Health Initiative Observational Study. GS5-07, San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 5-9, 2017.
16.
Strand F, Humphreys K, Holm J, et al: Large breast cancers in women attending regular screening: risk factors and implications for prognosis. Ann Meet Radiol Soc N Am; Nov 26-Dec 1, 2017, Chicago, IL.
17.
Wang F, Liu L, Cui S, et al: Distinct effects of body mass index and waist/hip ratio on risk of breast cancer by joint estrogen and progestogen receptor status: results from a case-control study in Northern and Eastern China and implications for chemoprevention. Oncologist 2017;22:1431-1443.
18.
Bjorner S, Rosendahl AH, Simonsson M, et al: Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer. Front Endocrinol (Lausanne) 2017;8:332.
19.
Gunter MJ, Hoover DR, Yu H, et al: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009;101:48-60.
20.
Kaaks R, Johnson T, Tikk K, et al: Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status - a prospective study within the EPIC cohort. Int J Cancer 2014;134:2683-2690.
21.
Neilson HK, Farris MS, Stone CR, Vaska MM, Brenner DR, Friedenreich CM: Moderate-vigorous recreational physical activity and breast cancer risk, stratified by menopause status: a systematic review and meta-analysis. Menopause 2017;24:322-344.
22.
Friedenreich CM: Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res 2011;188:125-139.
23.
Friedenreich CM, Cust AE: Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 2008;42:636-647.
24.
Lope V, Martin M, Castello A, et al: Physical activity and breast cancer risk by pathological subtype. Gynecol Oncol 2017;144:577-585.
25.
Boeke CE, Eliassen AH, Oh H, Spiegelman D, Willett WC, Tamimi RM: Adolescent physical activity in relation to breast cancer risk. Breast Cancer Res Treat 2014;145:715-724.
26.
Dallal CM, Brinton LA, Matthews CE, et al: Accelerometer-based measures of active and sedentary behavior in relation to breast cancer risk. Breast Cancer Res Treat 2012;134:1279-1290.
27.
Johnsson A, Broberg P, Johnsson A, Tornberg AB, Olsson H: Occupational sedentariness and breast cancer risk. Acta Oncol 2017;56:75-80.
28.
Nomura SJ, Dash C, Rosenberg L, Palmer J, Adams-Campbell LL: Sedentary time and breast cancer incidence in African American women. Cancer Causes Control 2016;27:1239-1252.
29.
Scoccianti C, Lauby-Secretan B, Bello PY, Chajes V, Romieu I: Female breast cancer and alcohol consumption: a review of the literature. Am J Prev Med 2014;46(3 suppl 1):S16-25.
30.
Harris HR, Willett WC, Vaidya RL, Michels KB: An adolescent and early adulthood dietary pattern associated with inflammation and the incidence of breast cancer. Cancer Res 2017;77:1179-1187.
31.
Toledo E, Salas-Salvado J, Donat-Vargas C, et al: Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial. JAMA Intern Med 2015;175:1752-1760.
32.
Terry PD, Miller AB, Rohan TE: Cigarette smoking and breast cancer risk: a long latency period? Int J Cancer 2002;100:723-728.
33.
Dossus L, Boutron-Ruault MC, Kaaks R, et al: Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer 2014;134:1871-1888.
34.
Glantz SA, Johnson KC: The surgeon general report on smoking and health 50 years later: breast cancer and the cost of increasing caution. Cancer Epidemiol Biomarkers Prev 2014;23:37-46.
35.
McKenzie F, Ferrari P, Freisling H, et al: Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study. Int J Cancer 2015;136:2640-2648.
36.
Ellingjord-Dale M, Vos L, Hjerkind KV, et al: Alcohol, physical activity, smoking, and breast cancer subtypes in a large, nested case-control study from the Norwegian Breast Cancer Screening Program. Cancer Epidemiol Biomarkers Prev 2017;26:1736-1744.
37.
Kuchenbaecker KB, Hopper JL, Barnes DR, et al: Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017;317:2402-2416.
38.
Howlader N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2013. Bethesda, National Cancer Institute, 2016.
39.
Liede A, Mansfield CA, Metcalfe KA, et al: Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment. Breast Cancer Res Treat 2017;165:433-444.
40.
Lubinski J, Huzarski T, Byrski T, et al: The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. Int J Cancer 2012;131:229-234.
41.
Narod SA: BRCA mutations in the management of breast cancer: the state of the art. Nat Rev Clin Oncol 2010;7:702-707.
42.
Friebel TM, Domchek SM, Rebbeck TR: Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. J Natl Cancer Inst 2014;106:dju091.
43.
Pettapiece-Phillips R, Narod SA, Kotsopoulos J: The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers. Cancer Causes Control 2015;26:333-344.
44.
King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643-646.
45.
Kotsopoulos J, Olopado OI, Ghadirian P, et al: Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2005;7:R833-843.
46.
Pijpe A, Manders P, Brohet RM, et al: Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat 2010;120:235-244.
47.
Neilson HK, Conroy SM, Friedenreich CM: The influence of energetic factors on biomarkers of postmenopausal breast cancer risk. Curr Nutr Rep 2014;3:22-34.
48.
Wang M, Yu B, Westerlind K, et al: Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland. Breast Cancer Res Treat 2009;115:213-220.
49.
Grill S, Yahiaoui-Doktor M, Dukatz R, et al: Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis. Arch Gynecol Obstet 2017;296:1135-1144.
50.
Pettapiece-Phillips R, Kotlyar M, Chehade R, et al: Uninterrupted sedentary behavior downregulates BRCA1 gene expression. Cancer Prev Res (Phila) 2016;9:83-88.
51.
Nkondjock A, Robidoux A, Paredes Y, Narod SA, Ghadirian P: Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat 2006;98:285-294.
52.
Nkondjock A, Ghadirian P: Diet quality and BRCA-associated breast cancer risk. Breast Cancer Res Treat 2007;103:361-369.
53.
Tryggvadottir L, Sigvaldason H, Olafsdottir GH, et al: Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. J Natl Cancer Inst 2006;98:116-122.
54.
Quante AS, Herz J, Whittemore AS, Fischer C, Strauch K, Terry MB: Assessing absolute changes in breast cancer risk due to modifiable risk factors. Breast Cancer Res Treat 2015;152:193-197.
55.
Digianni LM, Rue M, Emmons K, Garber JE: Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations. Cancer Epidemiol Biomarkers Prev 2006;15:70-75.
56.
Spector D: Lifestyle behaviors in women with a BRCA1 or BRCA2 genetic mutation: an exploratory study guided by concepts derived from the Health Belief Model. Cancer Nurs 2007;30:E1-10.
57.
Kim SJ, Zuchniak A, Sohn KJ, et al: Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: a prospective study. Am J Clin Nutr 2016;104:671-677.
58.
Wright CE, Harvie M, Howell A, Evans DG, Hulbert-Williams N, Donnelly LS: Beliefs about weight and breast cancer: an interview study with high risk women following a 12 month weight loss intervention. Hered Cancer Clin Pract 2015;13:1.
59.
Kiechle M, Engel C, Berling A, et al: Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial. Trials 2016;17:368.
60.
Kiechle M, Dukatz R, Yahiaoui-Doktor M, et al: Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers - an interventional randomized controlled multicenter trial (LIBRE-1). BMC Cancer 2017;17:752.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.